Assistant Professor, Joint with Cancer
Center, College of Human Medicine
Our research interests focus on the role
played by the estrogen receptor (ER) in breast tumor cell growth. One aspect of
this work involves an investigation of ER mRNA splicing variants and their
ability to modulate the expression of estrogen-responsive genes in breast tumor
cells.Our current thinking is centered on “non-classical”
pathways for regulation of transcription that are independent of direct DNA
binding and, instead, involve association of ER with other transcription factors
such as AP-1 and Sp1. Other projects under development includeexploiting gene expression data from public databases to identify novel
serum markers for breast cancer and exploring new techniques for targeted gene
disruption in somatic cells, with the goal of permitting functional analysis of
important regulatory proteins in their natural cell context.
Bollig A. and Miksicek R.J. An estrogen receptor-alpha splicing variant mediates both positive and negative effects on gene transcription. Mol. Endocrinol. 14:634-649, 2000.
Bunone G., Briand P.A., Miksicek R.J., and Picard D. Activation of the unliganded estrogen receptor by EGF involves the MAP kinase pathway and direct phosphorylation. EMBO J. 15:2174-2183, 1996.Other Publications
This will open a new browser window and connect you in to the NIH Entrez search
engine. Please, close the new window to come back to this page.
Return to Index